Stocks
BridgeBio (BBIO) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -688.9% | -5 684% | -774.1% | -455.5% | -6 177% | -208.8% | ||
| Changes by years, y/y, % | -4 995pp | +4 909pp | +319pp | -5 721pp | +73.0% | ||||
BridgeBio. EBITDA margin, %
BridgeBio. EBITDA margin, changes, pp
BridgeBio (BBIO) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | -6 441% | -8 223% | -3 855% | -9 698% | 2.53% | -208.8% | |
| Changes by years, y/y, % | +2 794pp | -8 261pp | +29 787pp | -3 661pp | +6 443pp | |||
| Changes by quarters, q/q, % | -404pp | -1 782pp | +4 368pp | -5 843pp | +9 700pp | |||
